CC chemokines constitute a novel class of cytokines that attract and activate monocytes and lymphocytes, as well as basophil and eosinophil lenkocytes, with distinct target cell profiles, and are believed to be involved in the regulation of different types of inflammation. The action of the recently identified monocyte chemotactic protein 3 (MCP-3) on human basophil and eosinophil function was studied and compared with that of other CC chemokines. In basophils, MCP-3, MCP-1, P.ANTES, and macrophage inflammatory protein (MIP)-loe all induced cyrosolic-frce calcium concentration ([Ca 2 + ]i) changes and, with different efticacies, chemotaxis (R_ANTES --MCP-3 >> MCP-1 > MIP-lc~), histamine release (MCP-1 = MCP-3 >> P.ANTES > MIPlc 0' and leukotriene C4 formation, after IL-3 pretreatment (MCP-1 = MCP-3 >> RANTES > MIP-loe). Thus, MCP-3 was as effective as MCP-1 as an inducer of mediator release, and as effective as R.ANTES as a stimulus of basophil migration. In contrast to MCP-1, MCP-3 was also a stimulus for eosinophils, and induced [Ca2+]i changes and chemotaxis as effectively as R.ANTES, which is the most potent chemotactic cytokine for these cells. Desensitization of the transient changes in [Ca2+]i was used tO assess receptor usage. In basophils, stimulation with MCP-3 prevented responsiveness to MCP-1 and R.ANTES, but not to MIP-loe. No single CC chemokine (except for MCP-3 itse~ affected the response to MCP-3, however, which was prevented only when the cells were prestimulated with both MCP-1 and R.ANTES. In eosinophils, by contrast, cross-desensitization between R.ANTES and MCP-3 was obtained. P.ANTES and to a lesser extent MCP-3 also desensitized eosinophils toward MIP-lce. The desensitization data suggest the existence of three chemokine receptors: (a) a MCP-1 receptor expressed on basophils but not eosinophils that is activated by MCP-1 and MCP-3; (b) a RANTES receptor in basophils and eosinophils that is activated by R.ANTES and MCP-3; and (c) a MIP-lce receptor that is activated by MIP-loe, R.ANTES and, more weakly, by MCP-3. This study shows that MCP-3 combines the properties of R.ANTES, a powerful chemoattractant, and MCP-1, a highly effective stimulus of mediator release, and thus has a particularly broad range of activities toward both human basophil and eosinophil lenkocytes.
A few years ago, chemotactic cyt0kines (now termed chemokines) were viewed as attractants for neutrophils (CXC chemokines) or mononuclear cells (CC chemokines). It was then found that IL-8 induces histamine and lenkotriene (LT)tC,4 release from IL-3-primed human blood basophils (1, 2) via GTP-binding protein-coupled receptors (3) . Later studies showed that some CC chemokines activate basophil as well as eosinophil lenkocytes, suggesting that they may function 1Abbra, iations used in this paper: [Ca2+] i, cytosolic-free calcium concentration; LT, leukotriene; MCP, monocyte chemotactic protein; MIP, macrophage inflammatory protein.
as mediators in allergic conditions and parasitic infestations. Several laboratories reported recently that monocyte chemotactic protein (MCP)-I is a powerful stimulus of histamine release from human blood basophils (4) (5) (6) . Priming of the ceUs with IL-3, IL-5, or GM-CSF enhanced histamine release and conditioned the cells to produce peptido-lenkotrienes in response to MCP-1, which was considerably more potent and effective than 6) . Significant but less pronounced release was observed in primed basophils upon stimulation with RANTES and macrophage inflammatory protein (MIP)-lot (7) (8) (9) . A direct comparison recently confirmed that MCP-1 is superior to R.ANTES as a stimulus of histamine and LTC4 release, and showed that tLANTES is considerably more potent than MCP-1 as a basophil chemoattractant (9) . R.ANTES and MIP-loe are also potent chemoattractants for eosinophil leukocytes, while MCP-1 is totally inactive on these ceils (10) .
A novel CC chemokine was recently identified in the supernatants of osteosarcoma call cultures (11) , and termed MCP-3 because of its marked sequence similarity with MCP-1. The cDNA coding for this chemokine was cloned and expressed (12, 13). We have now studied the effects of recombinant MCP-3 on human basophil and eosinophil leukocytes in comparison with MCP-1, tLANTES, and MIP-lcx. Our results show that MCP-3 stimulates both types of leukocytes, inducing cytosolic-free calcium changes, chemotaxis, and release of histamine and LTC4. As highly effective chemoattractant and inducer of mediator release, MCP-3 combines the properties of MCP-1 and ILANTES, and thus represents a most effective chemokine for basophil and eosinophil leukocytes.
Materials and Methods
Reagents. Dextran and FicoU-Hypaque were obtained from Pharmacia Fine Chemicals (Uppsala, Sweden); EDTA and fura-2/AM were from Fhh AG (Buchs, Switzerland); Hepes was from Calbiochem-Behring Corp. (La Jolla, CA); BSA (fatty acid free) was from Boehringer (Mannheim, FR.G); ionomycin was from Sigma Chemical Co. (St. Louis, MO). All other chemicals were of highest purity available.
Cytokines. Recombinant human MCP-1, ILANTES, MIP-loe, and MIP-I~ were purchased from Prepro Tech Inc. (Rocky Hill, NJ) and MCP-3 was prepared as described by Minty et al. (12) . Recombinant human IL-3 and IL-8 were kindly provided by Sandoz Ltd. (Basal, Switzerland and Vienna, Austria). All proteins were dissolved in 20 mM Hepes buffer, pH 7.4, containing 1 mg/ml BSA at 10 -s M, and stored at -70~ Cells. Basophil and eosinophil leukocytes were prepared from freshly drawn venous blood of unselected healthy volunteers as described previously (6, 9) . Basophlls were purified by centrifugation on a discontinuous Percoll gradient followed by negative selection with magnetic beads coated with mAbs against CD3, CD4, CDS, CD14, CD16, and CD19 (9) . The final preparation consisted of 80-95% basophils and 5-20% small lymphocytes, and the recovery was 30-60%. Eosinophils were purified to 99.5% by combining Percoll density gradient centrifugation and negative selection with anti-CD16 mAb-conjugated immunomagnetic beads (10) .
Histamine and LTC4 Release. Basophils (80-180 x 10Vml) in 20 mM Hepes, pH 7.4, containing 125 mM NaC1, 5 mM KC1, 1 mM MgClz, 1 mM CaC12, 0.5 mM glucose, and 0.025% BSA were warmed to 37~ exposed to Ib3 (10 ng/ml) or vehicle for 10 min, and then challenged with a chemokine. After 20 min, the tubes were placed in ice, and histamine and LTC4 were measured in the cell supernatant (14). Histamine release was expressed in percent of the total content of the sample (determined after call lysis). LTC4 generation was expressed as picograms LTC4/D4/E4 per nanogram total histamine (which corresponds to "~1,000 basophiJs).
Chemotaxi~ Chemotactic chambers with 48-well (Neuro Probe, Cabin John, MD) and polyvinyl-Fyrrolidone-free polycarbonate filters with 5-/~m pores (Nucleopore, Pleasanton, CA) were used and the assays performed as described previously (9, 10) . After incubation at 37~ in 5% COz for 60 min the filter was removed, washed, fixed, and stained, and the migrated cells were counted in five randomly sdected fields of 0.03 mm z. Cakium ~[Ca2+] .~ Changes. Purified eosinophils or basophils were loaded with fura-2/AM (0.3 nmol/106 cells) in 20 mM Hepes, pH 7.4, containing 125 mM NaCI, 5 mM KCI, I mM MgC12, 1 mM CaClz, 0.5 mM glucose, and 0.025% BSA for 30 rain at 370C, and [Ca2+]i changes were determined after chemokine stimulation (9) . In all experiments, stimulation with CC chemokines was followed by Ib8 and C5a as controls that showed preserved responsiveness of the cells to these two agonists. After each measurement maximum and minimum fluorescence was calibrated by addition of 5 /zM ionomycin followed by 1 mM MnC12.
Cytosolic-free

Results
Activation of Basophils and Eosinophils. All four chemokines
tested induced the migration of human blood basophils. As shown in Fig. 1 A, MCP-3 and ILANTES were highly effective and almost equally potent. Significant, but considerably weaker migration was observed with MCP-1 and MIP-lo~. Of the four active chemokines, MIP-lo~ had the lowest efficacy, while its homologue MIP-I~ was inactive as shown previously (9) . MCP-1 and MCP-3 also induced a marked, concentration-dependent release of histamine by cells that were not primed with IL-3 or another mydoid growth factor. In cells from unsdected donors, as used in this study, RANTES showed only borderline effects and MIP-lcx was inactive ( Fig.  1 B) . Exocytosis was very rapid and virtually complete within 1 rain after stimulation with MCP-3 or the other chemokines. No CC chemokine induced the generation of LTC4 in unprimed cells.
Priming with IL-3 expectedly enhanced the sensitivity of the cells as shown by a shift to the left of the concentration dependence curve, the higher amounts of histamine released, and the production of LTC4 (Fig. 2) . MCP-1 and MCP-3 were about equally active and considerably more effective than P.ANTES and MIP-lcx, which induced only low levels of release of either product. Since IL-3-primed basophils are particularly sensitive to stimulation, MIP-1/3 was also tested, but no activity was found (Fig. 2) .
MCP-3, KANTES, and MIP-lol induced chemotaxis and a rise in cytosolic-free calcium concentration ([Ca2+] i) in human eosinophils, while MCP-1 was completely inactive (Fig. 3) . Although tLANTES and MIP-lol were chemotactic at lower concentrations, MCP-3 showed high e~cacy and induced the migration of similar numbers of ceils as tLANTES. The maximal chemotactic index obtained for eosinophils and basophils after stimulation with either MCP-3 and R.ANTES was well above 20 in all experiments performed. As previously shown for P_ANTES (10) , the migration of basophils and eosinophils towards MCP-3 was due to a chemotactic rather than chemokinetic effect, since there was little migration when the chemokine was placed on both sides of the filter (data not shown). The activities of R.ANTES and MIP-lo~ are in agreement with former observations (10) , but the high effectiveness of MCP-3 was surprising since this chemokine shares "~70% sequence identity with MCP-1, which does not stimulate eosinophils. Rec~tors. Earlier studies had suggested that basophil and eosinophil leukocytes bear different types of CC chemokine receptors (9, 10) . Desensitization experiments were, therefore, performed to gain information on the types of receptors involved in the activation by MCP-3. To compare basophil and eosinophil responses, [Ca 2 + ]i changes were used to assess receptor activation. As shown in Fig. 4 , stimulation with MCP-3 abrogated the response of basophils to a subsequent stimulation with either R.ANTES or MCP-1. The [Ca2+]i rise induced by MCP-3, by contrast, was not affected by prior stimulation with MCP-1, R.ANTES, or MIP-la (data for MIP-loe not shown). The effect of sequential additions of several chemokines was then studied. As shown in Fig. 5 , the [Ca 2 + ]i rise induced by MCP-3 was prevented only when the cells were first stimulated with the combination of MCP-1 and RANTES (Fig. 5 A) . Prestimulation with MCP-1 and MIP-loz or with MIP-Iot and RANTES did not abolish the MCP-3 response. The effects as described were independent of the order of addition of the two chemokines before MCP-3, and in all cases, basophils remained responsive to IL-8, indicating that [Ca2+]i changes could still be induced by stimulation via CXC chemokine receptors.
Together, the results of these experiments indicate that MCP-3 acts on basophils via two receptors, one with selectivity for MCP-1, and the other with selectivity for RANTES. affected both (prestimulation with MCP-1 and RANTES). The finding that stimulation with MCP-3 prevented basophil responses to either MCP-1 or RANTES (Fig. 4) , but not to MIP-lol (Fig. 5 D) suggests the presence of a third receptor with sdectivity for MIP-lcx. The desensitization patterns indicate that the situation is somewhat different for ensinophils. It was known from a former study that these cells do not respond to MCP-1 (10) , and in fact, we observed no [CaZ+]i changes and a subsequent challenge with MCP-3 was not affected when eosinophils were exposed to MCP-1 (data not shown). If eosinophils lack a receptor for MCP-1, the action of MCP-3 could be mediated by the RANTES receptor, in which case cross-desensitization between MCP-3 and RANTES would be expected. Fig. 6 A shows that this is indeed the case. In agreement with a previous study (10) , desensitization was also observed when eosinophils were stimulated with R.ANTES followed by MIP-lcx, but not vice versa (Fig. 6 C) , indicating that RANTES also acts on the MIP-lot receptor. MCP-3, however, affected only slightly the response of eosinophils to MlP-hx ( Fig. 6/3 ), suggesting that it interacts with the MIP-lo~ receptor less effectively than RANTES. This may explain why RANTES prevented the response to MCP-3, while MCP-3 did not completdy abolish the response to RANTES (Fig. 6 A) . The response to R.ANTES was abrogated by combined prestimulation with MCP-3 and MIP-lo~, further indicating that RANTES acts on eosinophils via two distinct receptors (data not shown).
Discussion
Ikecent studies have indicated that CC chemokines are powerful stimuli of basophil and eosinophil lenkocytes. Three chemokines act on basophils: MCP-1 induces preferentially mediator release (4) (5) (6) , while RANTES and MIP-lo~ are more Time (s) Figure 5 . Desensitization of basophils by sequential stimulation with CC cheraokin~ l~'a-2-1oaded cells (10S/ml) west sequentially stimulated with two CC chemokines and then with MCP-3. IL8 was u__,ed as the hst stimulus to show that the ceils could still respond by mobilizing Ca 2+ . All chemokines were used at 50 nM. [Ca2*li-dependent fluorescence changes are shown. All stimulus sequences were tested at least three times with ceils from different uuselected donors, and identical desensitization patterns were obtained, The only variability observed was a slight donor-to-donor difference in the maximal [Ca2+]ilevels induced by different chemokines, in particular by .
effective as chemoattractants (7) (8) (9) . R.ANTES and MIP-lcx also activate eosinophils (10, 15) . It was, therefore, of interest to study the effects of MCP-3, a novel CC chemokine structurally related to MCP-1 (11) (12) (13) . We have found that MCP-3 has the broadest spectrum of activity of all chemokines studied; it was as effective as MCP-1 as an inducer of mediator release in basophils, and as effective as RANTES as a stimulus of basophil and eosinophil migration. The fact that MCP-3 induced histamine release with similar efficacy to MCP-1 was expected because these chemokines share >70% sequence identity. Its potent chemotactic activity, and in partio_da_r its action on eosinophils, were surprising, however, since the sequences of MCP-3 and RANTES are only distantly rehted (25% sequence identity). It thus appears that sequence homology is not necessarily predictive for the capacity of ~t CC chemokines to activate one or the other effector rune- tions in basophils and eosinophils, and that activity is more likely to depend on discrete sequence motifs. Desensitization analysis with real-time recording of a rapid response like the transient change in [Ca z+ ]i is a sensitive way to assess receptor usage by related agonists, and the method of choice when only low numbers of cells are available, as in the present study. In such experiments evidence was obtained for the existence of distinct receptors for MCP-1 and RANTES on basophils (9, 10) , and the present results suggest that MCP-3 not only shares the biological activities of two rehted chemokines, but also interacts with their receptors. Stimulation with MCP-3 abrogated responsiveness to MCP-1 and RANTES. To prevent the response to MCP-3, however, prestimulation with both MCP-1 and RANTES was required. In eosinophils (which do not respond to MCP-1 and do not appear to express MCP-1 receptors) by contrast, RANTES alone was sufficient to fully desensitize the cells towards MCP-3.
In addition to the two receptors that are shown here to mediate the effects of MCP-3, our previous studies (9, 10) had suggested the existence of a third CC chemokine receptor in basophils and ensinophils with a high affinity for MIP-lot and a somewhat lower affinity for RANTES. MCP-3 was less effident than RANTES in desensitizing the cells toward MIP-lc~, suggesting that RANTES is a better ligand. This MIP-lo~ receptor may correspond to a recently cloned CC chemokine receptor (16, 17) that binds MIP-lc~ with high affinity and also interacts with RANTES. A MIP-lc~ receptor is also present in human neutrophils, where MIP-lo~ and to a lesser extent R.ANTES were shown to elicit [Ca2+] i changes, but no chemotaxis or exocytosis (17, 18) . We have found that MCP-3 induces similar [CaZ+]i changes, but no functional responses in neutrophils, and that these changes are prevented by prestimulation with MIP-lob (data not shown). On the other hand, in the present study, the responses ofbasophils to MCP-1 and MCP-3, and of eosinophils to RANTES and MCP-3 were not affected by prestimulation with MIP-lol, suggesting that the recently cloned receptor for MIP-lo~ mediates other functions.
Our results suggest the existence of three chemokine receptors: (a) a MCP-1 receptor expressed on basophils but not eosinophils that is activated by MCP-1 and MCP-3, and mediates predominantly mediator release; (b) a RANTES receptor in basophils and eosinophils that is activated by RANTES and MCP-3, and mediates mainly chemotaxis; and (c) a MIP-lo~ receptor in basophils, eosinophils, and neutrophils that is activated by MIP-lc~, R.ANTES, and, more weakly, by MCP-3. The function of the MIP-lcr receptor is still unclear. These conclusions are so far largely based on functional assays and desensitization studies, and other interpretations are also possible. Heterologous desensitization of caldum transients induced by CSa and FMLP has been reported, particularly when the time interval between the two agonists is 5 min or more, and when the concentration of the second stimulus is suboptimal (19). We, therefore, cannot exclude the presence of additional rccepto~ (e.g., MCP-3-specific receptors) that cross-deactivate other CC chemokine receptors, although we observed virtually no cross-desensitization of calcium transients in different grannlocyte types sequentially stimulated with a large number of different agonists (CC chemokines, IL-8, C5a, C3a, FMLP), provided that they are used at high (50-100 riM) concentrations within short (60-90 s) time intervals (3, 6, 9, 10; and our unpublished observations) . Lack of desensitization between two chemoattractants, however, strongly indicates activation through distinct receptors since we always observe full desensitization upon sequential exposure to the same agonist, although one cannot definitely exclude the possibility that a receptor occupied by one agonist can still be activated with another distinct ligand. Nevertheless, deactivation studies as performed here, particularly when combined with functional studies, appeared to be surprisingly predictive for the ligand sdectivities of subsequently cloned chemoattractant receptors. For example, the recently cloned MIP-lol receptor is also activated by RANTES (16, 17) as suggested in our p~ous studies (9, 10) , despite the fact that MIP-lo~ binding is displaced by RANTES no more effldently than by other CC chemokines such as MCP-1 (16). Thus, deactivation of calcium transients can even give information that is not obtainable with studies of equilibrium binding at 4~ We therefore believe that the model proposed above provides a reasonable and likely explanation of our observations, and gives a minimal estimate of different CC chemokine receptors present on basophils and eosinophils. However, additional information on ligand binding and cell activation is certainly needed using cells that express single CC chemokine receptors isolated by cloning.
Owing to their effects on mononuclear cells, basophils,
755
Dahinden et al. Brief Definitive Report and eosinophils, CC chemokines must be regarded as major potential mediators of effector cell recruitment and activation in different types of chronic inflammation. Their actual involvement in the pathogenesis of such conditions will depend, in addition, on their expression in the affected tissues. In this regard, it is interesting that a novel murine chemokine with homology to MCP proteins, which was termed MARC, is expressed preferentially by murine mast cells and mast cell lines (20). The 3' noncoding region of the MARC and human MCP-3 cDNAs are highly homologous, suggesting that MARC may be the routine analogue of human . MCP-3 may, therefore, play a major role in the pathogenesis of hypersensitivity diseases such as asthma and parasitic infestations. MCP-1 and KANTES are CC chemokines with dearly distinct profiles of activity. The present results underline the potential importance of MCP-3 as an activator and an attractant of inflammatory cells since it combines, at least on basophils and eosinophils, the biological activities of MCP-1 and KANTES.
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